HCA Healthcare Q3 revenue $16.21B, EPS $3.91; FY 2023 guidance revised; dividend $0.60

HCA Healthcare, Inc.

2023-Q3 EPS reported $13.07 revenue$47,665,000,000

Revenue $16.213B (+8.3% YoY); net income $1.079B ($3.91 diluted EPS, flat vs $3.91 prior year).
Adjusted EBITDA $2.88B, down from $2.902B; same-facility admissions +3.4%, equivalent admissions +4.1%.
FY 2023 guidance revised: revenue $63.5-$64.5B, adjusted EBITDA $12.3-$12.6B, EPS $17.80-$18.50.
Board declared $0.60/share dividend payable Dec 28 to holders of record Dec 14; Q3 buyback $1.14B, $1.685B remaining.
CEO cited solid demand but Valesco physician staffing JV performed below expectations.

item 2.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HCA Healthcare, Inc. updated its year ending December 31, 2023 guidance (reaffirmed).

Period: year ending December 31, 2023
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

The 2023 guidance ranges for the year have been revised from our second quarter release as follows: Previous 2023 Guidance Range as of July 27, 2023 2023 Guidance Range as of October 24, 2023 Revenues $63.25 to $64.75 billion $63.5 to $64.5 billion Net Income Attributable to HCA Healthcare, Inc. $4.900 to $5.255 billion $4.940 to $5.130 billion Adjusted EBITDA $12.3 to $12.8 billion $12.3 to $12.6 billion EPS (diluted) $17.70 to $18.90 per diluted share $17.80 to $18.50 per diluted share

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

HCA Healthcare, Inc. reported third quarter ended September 30, 2023 results: revenue $16.213 billion, net income $1.079 billion, EPS $3.91 per diluted share.

Period: third quarter ended September 30, 2023
Revenue: $16.213 billion
Net income: $1.079 billion
EPS: $3.91 per diluted share
Result: reported results

Exact text from the filing

results for the third quarter ended September 30, 2023. Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted): ● Revenues totaled $16.213 billion ● Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share ● Adjusted EBITDA totaled $2.880 billion ● Cash flows from operating

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-261204

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.